Xingruida XDR
GHK-Cu
Finnrick tested 8 samples of GHK-Cu from Xingruida XDR between 25 Nov 2025 and 9 Feb 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).
Finnrick Rating™
Xingruida XDR
GHK-Cu
Tested 8 Samples
Last test 9 Feb 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other GHK-Cu tests from top-rated vendors:
All GHK-Cu tests from Xingruida XDR
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
9 Feb 2026
First
25 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 9 Feb 2026 | View | 100mg | 54.8mg | -45.2% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 4 Feb 2026 | View | 100mg | 54.9mg | -45.1% | 99.90% | n/a | CU 100 | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 19 Jan 2026 | View | 100mg | 144mg | +44.0% | 99.95% | n/a | 12/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 6 Jan 2026 | View | 50mg | 49.4mg | -1.2% | 99.95% | n/a | 2025.02.27 | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 6 Jan 2026 | View | 50mg | 48mg | -4.0% | 99.89% | n/a | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 29 Dec 2025 | View | 100mg | 105mg | +5.0% | 99.95% | n/a | (no batch ID) | White Label / Silver Crimp / Red Cap | Lab E | Public | |
| 25 Nov 2025 | View | 100mg | 115mg | +15.0% | 99.92% | not detected | SKU007 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 25 Nov 2025 | View | 50mg | 48.3mg | -3.4% | 99.48% | n/a | CU50-10022025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |